drugset / Trial / NCT00028522
R(+)XK469 in Treating Patients With Advanced Neuroblastoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase I trial is studying the side effects and best dose of R(+)XK469 in treating patients with advanced neuroblastoma. Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die.
Timeline
- Start
- 2001-12
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | R(+)XK469 | Small molecule | — | Intravenous |